What amount sold does ShawSpring Partners Fund, L.P. report in Form D filings?

The latest linked filings report $474.7M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ShawSpring Partners Fund, L.P.'s most recent SEC filing?

ShawSpring Partners Fund, L.P.'s most recent Form D filing was on 2021-06-11.

How many investors does ShawSpring Partners Fund, L.P. have?

The most recent Form D filing lists 96 investor(s).

ShawSpring Partners Fund, L.P.

CIK: 0001613882·Pooled Investment Fund·BOSTON, MA·Limited Partnership

Reported Sold

$474,686,285

Total Filings

Identified Offerings

Last Filed

Jun 11, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Jun 11, 2021Form D/A — Amendment

Reported sold: $474,686,285 · Target: Indefinite

Rule 506(b)·96 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 7, 2020Form D/A — Amendment

Reported sold: $166,702,317 · Target: Indefinite

Rule 506(b)·52 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 8, 2019Form D/A — Amendment

Reported sold: $26,365,317 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 5, 2018Form D/A — Amendment

Reported sold: $24,656,817 · Target: Indefinite

Rule 506(b)·21 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jun 2, 2017Form D/A — Amendment

Reported sold: $23,171,817 · Target: Indefinite

Rule 506(b)·16 investors·Section 3(c), Section 3(c)(1)

Jun 15, 2016Form D/A — Amendment

Reported sold: $23,171,817 · Target: Indefinite

Rule 506(b)·16 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors, Exemptions

Jul 6, 2015Form D/A — Amendment

Reported sold: $12,868,536 · Target: Indefinite

Rule 506(b)·13 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors, Exemptions

Jul 23, 2014Form D — New notice

Reported sold: $10,000,000 · Target: Indefinite

Section 3(c)·1 investor·Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

88%

Latest reported sold across 1 identified offering

$474,686,285

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

-S

-- ShawSpring Partners GP, LLC

Related Person

Appears on 8 filings

ShawSpring Partners GP, L.P.

Related Person

Appears on 8 filings

-S

-- ShawSpring Partners, LLC

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 11, 2021	Amendment	Indefinite	$474,686,285	96
Jul 7, 2020	Amendment	Indefinite	$166,702,317	52
Jul 8, 2019	Amendment	Indefinite	$26,365,317	27
Jul 5, 2018	Amendment	Indefinite	$24,656,817	21
Jun 2, 2017	Amendment	Indefinite	$23,171,817	16
Jun 15, 2016	Amendment	Indefinite	$23,171,817	16
Jul 6, 2015	Amendment	Indefinite	$12,868,536	13
Jul 23, 2014	New	Indefinite	$10,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026